CircRNAs in lung cancer- role and clinical application.
Biomarker
Circular RNAs
Pathophysiology
miRNA sponge
Journal
Cancer letters
ISSN: 1872-7980
Titre abrégé: Cancer Lett
Pays: Ireland
ID NLM: 7600053
Informations de publication
Date de publication:
28 09 2022
28 09 2022
Historique:
received:
22
03
2022
revised:
01
06
2022
accepted:
27
06
2022
pubmed:
6
7
2022
medline:
10
8
2022
entrez:
5
7
2022
Statut:
ppublish
Résumé
Lung cancer holds the highest mortality rate among malignancies worldwide. Nevertheless, the potential molecular mechanisms of its tumorigenesis and evolution remain obscure. Circular RNAs (circRNAs), a broad category of covalently closed molecules, follow a malignancy-restricted expression pattern. Leading-edge studies have demonstrated the clinical application prospects of circRNAs in lung cancer. Herein, this review elucidates the biogenesis, biological functions, and pathophysiology of circRNAs. Furthermore, we underscore the forefront of the diagnostic, prognostic, and therapeutic potential of circRNAs in lung cancer as well as discuss the bottleneck that needs to be overcome to translate the basic advances of circRNAs into clinical practice.
Identifiants
pubmed: 35780929
pii: S0304-3835(22)00294-4
doi: 10.1016/j.canlet.2022.215810
pii:
doi:
Substances chimiques
RNA, Circular
0
RNA
63231-63-0
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
215810Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.